Category: Medicine Page 1 of 7

Of course there will be medicine. I am The Grumpy Doc.

Here’s a sobering statistic to kick things off: fewer than 15% of people ages 65 and older meet the federal Physical Activity Guidelines. That’s despite the mountain of evidence showing that regular movement is one of the most powerful tools we have for aging well. Physical activity helps prevent and manage chronic diseases like heart disease, diabetes, and obesity, and for older adults specifically, it reduces the risk of falling, supports more years of independent living, and improves brain health.

The good news? It’s never too late to start, and even modest improvements make a real difference. This guide breaks down what exercise should look like at different stages of older adulthood — beginning with a starter plan for newcomers and building into a long-term maintenance approach.

The Foundation: What Every Senior Needs

Before diving into age-specific details, it helps to understand the three pillars of senior fitness. To get substantial health benefits, older adults need three types of activity each week: moderate- or vigorous-intensity aerobic exercise, muscle-strengthening activities, and balance training.

The target, according to both the WHO and CDC, is 150 minutes of moderate-intensity aerobic activity combined with 2–3 days of strength training per week, along with balance and flexibility exercises.

That said, these numbers aren’t a cliff — they’re a destination. For someone who hasn’t exercised in years, starting with 10 minutes of walking three times a week is a legitimate and meaningful beginning.

The Beginning Plan: Weeks 1–12

The biggest mistake new exercisers make at any age is doing too much too soon. For seniors, that’s not just discouraging — it can lead to injury. The goal of the first three months is to build a habit and establish a safe baseline, not to hit peak performance.

Week 1–4: Getting Moving

Start with walking. It’s free, low-impact, and one of the most studied forms of exercise in older adults. Aim for 10–15 minutes of brisk walking (meaning you can talk but not sing) on three days per week. Pair this with two days of very light strength work — seated leg raises, wall push-ups, and chair-assisted squats are all good options. On the same days as strength work, spend 5–10 minutes on gentle stretching and simple balance exercises like standing on one foot while holding a chair. This isn’t glamorous, but it works.

Week 5–8: Building Consistency

Extend walking sessions to 20–25 minutes and add a fourth day if possible. For strength training, begin using light resistance bands or small hand weights. Aim for 8 to 12 repetitions per exercise, which counts as one set, and try to do at least one set of muscle-strengthening activities — working up to two or three sets for more benefit. Continue balance work daily if possible, even if just 5 minutes of standing on one foot near a wall.

Week 9–12: Progressing Toward the Target

By the end of this phase, the goal is to be walking 30 minutes on most days, doing strength training twice a week, and building some basic balance confidence. Many people find water aerobics or a beginner yoga class fits well here — these are what researchers call “multicomponent” activities that hit aerobic fitness, strength, and balance simultaneously.

The Maintenance Plan

Once the habit is established, the goal shifts to consistency and gradual improvement. The maintenance plan is simply a sustainable version of the full guidelines, adapted to fit daily life.

A solid maintenance week might look like: three to four days of 30-minute brisk walks or light cycling, two days of resistance training targeting the major muscle groups (legs, back, core, and arms), and daily balance work woven into ordinary activities — standing on one foot while brushing teeth, walking heel-to-toe down a hallway. If you take a break due to illness or travel, start again at a lower level and slowly work back up.

Age 65: The “Just Starting” Window

At 65, most people are either newly retired or approaching it. Energy levels are generally still high, and the body is still reasonably responsive to new exercise demands.

The primary goals at 65 are cardiovascular health, maintaining muscle mass, and establishing the exercise habit before age-related decline accelerates. Strength training is especially important here because muscle loss (called sarcopenia) begins in earnest in the 60s. Weight-bearing activities like walking and resistance training also help preserve bone density.

At 65, most people can follow the full beginning plan above without major modification. Joint pain, if present, is best addressed by switching to low-impact options (pool walking, cycling, elliptical) rather than skipping exercise altogether. This is also an excellent time to get a checkup and mention your exercise plans to a doctor, particularly if you have any chronic conditions.

Age 70: Prioritizing Balance and Flexibility

By 70, the picture shifts somewhat. Muscle and bone loss continue, and reaction time begins to slow — which is why fall prevention becomes a central focus. One-third of older adults aged 65 and over fall each year, and 50% of those fall repeatedly. The risk rises significantly with each passing decade.

The research is clear on this point: balance training works. Balance measures in intervention studies showed improvements between 16% and 42% compared to baseline assessments. Activities like Tai Chi are particularly effective — Tai Chi interventions were associated with approximately 31–58% reductions in falls, the Otago Exercise Program with 23–40% reductions, and multimodal strength-balance training with 20–45% reductions.

At 70, the aerobic goal remains 150 minutes per week, but it’s smart to reduce session intensity slightly if needed and focus more time on balance and flexibility work. Yoga, Tai Chi, and water fitness classes are excellent choices. Strength training should continue, but with a greater emphasis on functional movements — exercises that mimic everyday activities like getting up from a chair or reaching overhead.

Age 75: Adapting Without Stopping

At 75, the conversation shifts from maximizing performance to protecting function and independence. The goal isn’t to work out like a 50-year-old — it’s to maintain the ability to live on your own terms.

Research suggests that neuromuscular impairments tend to worsen progressively with age, particularly in adults over 70, as natural age-related declines accelerate deterioration in reaction time, proprioception, and coordination. This makes structured balance training non-negotiable at this age.

Aerobic exercise may need to shift toward lower-impact formats: water aerobics, recumbent cycling, or simply slower, more deliberate walking. Strength training should continue at least twice a week, using lighter resistance with higher repetitions if heavy weights cause joint discomfort. Chair-based exercise programs are a reasonable option for those with limited mobility. Recovery time between sessions also gets longer with age, so spacing workouts out more evenly through the week becomes important.

One addition that becomes more relevant at 75: flexibility and mobility work. Spending 10–15 minutes on gentle stretching after every workout helps maintain the range of motion needed for daily activities like dressing, driving, and navigating stairs.

Age 80 and Above: Function First

At 80 and beyond, the fitness calculus is almost entirely about maintaining the ability to perform daily tasks safely and independently. That means the exercises themselves may look very different from what a 65-year-old does — and that’s perfectly appropriate.

The core principles don’t change: move every day, do some resistance work, and train your balance. But intensity drops, rest increases, and safety becomes the top priority. Chair-based strength exercises — seated leg lifts, ankle rotations, seated marching, resistance band pulls — are highly effective and much lower-risk than standing exercises for many people at this stage.

Balance work at 80+ should be done near a sturdy support surface. Even holding a chair while practicing a small weight shift from foot to foot provides meaningful benefit. Interventions with a total weekly dose of three or more hours that included balance and functional exercises were particularly effective, with a 42% reduction in the rate of falls compared to control.

Walking remains the single best aerobic exercise for this age group if mobility allows, even if sessions are shorter — 10 to 15 minutes, a few times a day, can accumulate to meaningful totals. Water-based exercise is especially valuable because buoyancy reduces joint stress while still providing resistance.

It’s worth noting that the emotional and social aspects of exercise become increasingly important at 80+. Group classes — whether at a senior center, community pool, or gym — provide motivation, accountability, and social connection alongside the physical benefits.

A Note on Medical Clearance

This guide is based on well-established public health guidelines, but individual health conditions vary enormously. Before starting any new exercise program, especially after 70, a conversation with a doctor or physical therapist is strongly recommended. That’s especially true if you’re managing heart disease, diabetes, severe arthritis, osteoporosis, or recent surgery.

Illustration generated by author using ChatGPT

Sources:

CDC Physical Activity for Older Adults: https://www.cdc.gov/physical-activity-basics/guidelines/older-adults.html

CDC: What Counts as Physical Activity for Older Adults: https://www.cdc.gov/physical-activity-basics/adding-older-adults/what-counts.html

ACSM Physical Activity Guidelines: https://acsm.org/education-resources/trending-topics-resources/physical-activity-guidelines/

Fall Prevention Exercise Effectiveness (PMC): https://pmc.ncbi.nlm.nih.gov/articles/PMC10435089/

Falls Prevention Systematic Review (MDPI): https://www.mdpi.com/2075-1729/16/1/41

WHO-informed Falls Evidence (IJBNPA): https://ijbnpa.biomedcentral.com/articles/10.1186/s12966-020-01041-3

Physical Activity in Older Adults (PMC): https://pmc.ncbi.nlm.nih.gov/articles/PMC11562269/

Balance and Physical Activity Programs (PMC): https://pmc.ncbi.nlm.nih.gov/articles/PMC6635278/

The Frozen Frontier: Understanding Cryonics and the Quest to Cheat Death

By John Turley

On February 23, 2026

In Medicine

The Cold Hard Facts

So, you’ve probably heard about cryonics—the practice of freezing dead bodies in hopes of future revival—whether from sci-fi movies, an episode of Twilight Zone, or news stories about tech billionaires planning for immortality. But is there any legitimate science behind it, or is it all wishful thinking dressed up in lab coats? Let’s dig into this fascinating and controversial field.

Fair warning: this topic gets technical fast. I’ll do my best to keep things accessible, but some science-speak is unavoidable. I won’t pretend to offer an exhaustive examination of every element—that would take a textbook, not a blog post.

First, Let’s Get Our Terms Straight

Before we dive in, there’s an important distinction to make. Cryogenics refers broadly to the science of producing and studying very low temperatures—generally below −150°C (−238°F). This is a legitimate field with real-world applications to everything from rocket fuel to medical equipment to food preservation.

Cryonics, on the other hand, is specifically the practice of preserving a person who has died, with the hope of reviving them sometime in the future. This is where things get speculative—and controversial.

The Scientific Foundations: How Did We Get Here?

The ability to produce extremely cold temperatures emerged from a deepening understanding of thermodynamics—the science of heat, energy, and work. The key theoretical developments happened between 1842 and 1852 when a number of scientists published foundational works on the first and second laws of thermodynamics.

The practical breakthrough came in 1877, when oxygen was first cooled to the point where it became a liquid (−183°C). The term “cryogenics” itself was coined in 1894 by Kamerlingh Onnes of the University of Leiden to describe the science of producing very low temperatures.

There is a theoretical lower limit to how cold anything can get, known as absolute zero: −273.15°C or −459.67°F. At that point, molecular motion essentially stops, though reaching it is physically impossible because the energy required approaches infinity.

The logic behind biological cryopreservation flows naturally from this: if cold temperatures slow and eventually halt chemical processes, then extreme cold could theoretically preserve living tissue indefinitely. At liquid nitrogen temperatures (−196°C), the chemical and biological reactions in cells slow dramatically—and in theory, stop—which is the core premise of cryonics.

A key conceptual pillar of cryonics is that “death” is a process, not a single moment: cells and tissues undergo a continuum of injury after circulation stops, and some damage that is irreversible today might be repairable with future nanotechnology or regenerative medicine. Technically, current procedures emphasize rapid cooling after legal death, cardiopulmonary support to circulate cold fluids, and perfusion of the vasculature with concentrated cryoprotectant solutions that aim to achieve vitrification (a glass‑like solid state with minimal ice).

The Ice Crystal Problem: Why Freezing Destroys Living Tissue

Here’s where things get complicated. While the physics of cold temperatures is well understood, the biology of what happens when you freeze living tissue is where cryonics runs into serious trouble.

Freezing is often catastrophic for cells. On the scale of organs, ice formation can cause mechanical damage through expansion and can literally shatter tissue. When ice forms inside a cell, that cell almost always dies. Wide scale freezing also disrupts capillaries and vessels so that even if the cells were intact, they could not be reperfused.

The brain presents particular challenges on top of all this. Neurons—the cells that form the biological basis of everything you are—are more intricate and vulnerable than any other cell type. They consume roughly a quarter of the body’s available energy just to keep themselves alive. And it’s not just the presence and number of neurons that supports consciousness and memory, but the extraordinarily precise way in which trillions of microscopic connections are arranged between them. Those connections are how your memories and identity are stored, and they are exactly the kind of delicate structures most vulnerable to freezing damage.

Vitrification: The Workaround

To sidestep the ice crystal problem, cryonicists developed a technique called vitrification—essentially turning the body into a glass-like solid without crystallization. The process involves replacing the body’s blood with a special solution of cryoprotectant chemicals. These compounds are believed to prevent ice crystal formation and reduce tissue damage. Bodies are then stored in specialized containers filled with liquid nitrogen at −196°C.

The idea is elegant: instead of freezing, you’re essentially turning biological tissue into an amorphous, glass-like state where nothing moves and nothing degrades. On paper, it sounds like a solution. In practice, it creates a whole new set of problems.

The Toxicity Problem: Cryoprotectants as a Double-Edged Sword

The chemicals that prevent ice formation are toxic to the cells they’re meant to protect, and that toxicity increases with concentration. You need high doses to stop ice from forming, but those same doses cause their own cellular damage.

Dimethyl sulfoxide (DMSO) is the most widely used cryoprotectant, and also the most problematic. It can trigger programmed cell death, induce unwanted cellular changes, create osmotic stress, and may be a potential neurotoxin. At higher concentrations, it may even promote tumor development.

Other cryoprotectants carry their own baggage. Glycerol, long used for preserving blood cells and sperm, simply doesn’t scale up for whole-organ preservation. Ethylene glycol—yes, the same compound found in automotive antifreeze—gets metabolized into glycolic acid, which can cause metabolic acidosis, destabilizes cell membranes and may disrupt protective water layers around critical biological molecules.

Researchers are actively pursuing alternatives, including antifreeze proteins, nanotechnology-based approaches and new cryoprotectants. Each target ice formation or membrane protection through mechanisms designed to reduce the toxicity trade-off that has plagued cryopreservation for decades, though none has yet solved the problem at the scale cryonics requires.

Can We Actually Revive Frozen Bodies?

Short answer: No. Not currently, and possibly not ever.

Dennis Kowalski, president of the Cryonics Institute, has acknowledged that cryonic reanimation is “100 percent not possible today.” Shannon Tessier, a cryobiologist with Harvard University and Massachusetts General Hospital, put it more bluntly: “…the harsh reality is that current cryonic methods give patients only false hope. As they are practiced, they are both unscientific and profoundly destructive, permanently damaging cells, tissues, and organs. For now, the dream of cryonics remains frozen.”

Even setting aside current limitations, revival would require solving an extraordinary stack of problems: repairing damage from oxygen deprivation prior to freezing, neutralizing cryoprotectant toxicity, addressing thermal fracturing that occurs during the cooling process, healing tissues that didn’t vitrify successfully, and then curing whatever originally caused death. In many cases, reversing aging would also be necessary. None of these are close to solvable today.

There’s also a deeply uncomfortable practical question embedded in all of this: even if future medicine could theoretically rebuild and restore neuronal connections, how would anyone know what connections belong where? While the scanning technology is advancing fast enough that reading a well-preserved brain’s connectome at molecular resolution looks plausible within the coming decades, whether that information would be sufficient to reconstruct a person — biologically or digitally — remains genuinely unknown. Unless a complete molecular-level brain scan is performed before freezing—and stored alongside the tissue—trying to reconstruct memories and personality would be like trying to rewrite a burned book by studying the ashes.

Nanotechnology and Recent Progress

Cryonicists often point to future nanotechnology as the solution to the repair problem. The central thesis is that nearly any structure consistent with the laws of chemistry and physics could theoretically be built at the molecular level. The idea is that tiny molecular machines could one day repair cellular damage caused by cryopreservation rapidly enough to make revival possible. This remains highly speculative, but it’s not impossible in theory.

There has been some genuine progress on the warming side of the equation. Scientists have developed methods for safely thawing frozen tissues using nanoparticles—specifically, silica-coated particles containing iron oxide. Tests on human skin cells, pig heart valve segments, and pig artery sections showed no signs of harm from the rewarming process, and the tissues preserved key physical properties like elasticity. Application at the whole organ level has yet to be demonstrated.

What Actually Works Today

It’s worth noting what cryopreservation can accomplish now. Medical laboratories have long used the technique to preserve animal cells, human embryos, and simple tissues—eggs, sperm, bone marrow, stem cells, corneas, and skin—for periods of up to three decades, with successful thawing and transplantation. This is established, working medicine.

The leap from preserving a cell or an embryo to preserving a whole human body, however, is enormous. Large vitrified organs tend to develop fractures during cooling. No one has successfully preserved and revived a large mammal from a fully vitrified state.

What About The Wood Frog?

Invariably, in the discussion of cryonics someone will bring up the wood frog. In northern climates, the wood frog can seemingly freeze solid in the winter and then be hopping around with no obvious injuries in the spring. But there are several reasons why this isn’t applicable to the human science of cryonics.

First, and most obvious, the wood frog is cold-blooded, and we are not. The wood frog survives freezing at -3°C to -16°C, while cryonics stores bodies at -196°C—temperatures no frog could survive. Crucially, wood frogs, thanks to eons of evolutionary adaptation, prepare biologically before freezing—their liver actively flooding tissues with glucose cryoprotectant through a functioning circulatory system. While most metabolic activity ceases, the frog’s cells remain alive throughout; cryonics begins with legally dead patients. Even Ken Storey, the leading wood frog researcher, is a prominent cryonics skeptic. The frog demonstrates cold-blooded animals can evolve freeze tolerance—not that dead mammals can be revived from liquid nitrogen temperatures.

The Bottom Line

Cryogenics as a branch of physics is legitimate, well-established science. Cryopreservation of cells, embryos, and simple tissues works and has real medical applications. Cryonics—preserving entire human bodies or brains for future revival—is built on legitimate scientific principles but requires technological capabilities that don’t exist and may never exist. The damage from freezing is extensive, cryoprotectants are toxic, and no proven method exists for repairing the accumulated harm, let alone reversing death itself.

One cryonicist summed it up honestly: “Most people do not think it’s going to work and they might be right.”

That said, given the remarkable arc of scientific progress over the past few centuries, it’s difficult to dismiss cryonics entirely. If the next few centuries bring comparable advances, arguing that tissue repair is inherently and forever impossible becomes harder to sustain.

For those who choose cryopreservation, it’s essentially a bet—a wager that future science will solve problems we can’t currently solve, using technologies we can’t currently imagine. Whether that’s a reasonable gamble or an expensive expression of unfounded technological faith is something each person has to decide for themselves.

There’s one practical question nobody seems to have a good answer for: if the technology to reanimate frozen bodies is ever developed, who pays for it? None of the current cryonics companies appear to have a clear idea of what future revival costs might look like, or what happens if the cost of maintaining storage outlives the payments made upfront. As it stands, collecting rent from the frozen is not a well-developed business model.

One last thought, more philosophical than technical. Just because science may one day be able to reanimate a cryonically preserved human, should we?

Illustration generated by author using ChatGPT

Sources:

NIST Cryogenics: https://trc.nist.gov/cryogenics/aboutCryogenics.html

Britannica on Cryogenics: https://www.britannica.com/science/cryogenics

Britannica on Cryonics: https://www.britannica.com/science/cryonics

National Library of Medicine-PMC – Scientific Justification of Cryonics: https://pmc.ncbi.nlm.nih.gov/articles/PMC4733321/

National Library of Medicine-PMC – Spending Eternity in Liquid Nitrogen: https://pmc.ncbi.nlm.nih.gov/articles/PMC3328517/

National Library of Medicine-PMC – Ice Inhibition for Cryopreservation: https://pmc.ncbi.nlm.nih.gov/articles/PMC7967093/

National Library of Medicine-PMC – Cryoprotectant Toxicity: https://pmc.ncbi.nlm.nih.gov/articles/PMC4620521/

National Library of Medicine-PMC – Cryopreservation Overview: https://pmc.ncbi.nlm.nih.gov/articles/PMC7995302/

National Library of Medicine-PMC – Cryopreservation of Animals and Cryonics: https://pmc.ncbi.nlm.nih.gov/articles/PMC9219731/

BMC Biology – Winter is Coming: https://link.springer.com/article/10.1186/s12915-021-00976-8

Live Science on Nanowarming: https://www.livescience.com/58098-nanotech-may-revive-frozen-organs.html

MIT Technology Review on Cryonics: https://www.technologyreview.com/2022/10/14/1060951/cryonics-sci-fi-freezing-bodies/

The Conversation on Cryonics: https://theconversation.com/will-we-ever-be-able-to-bring-cryogenically-frozen-corpses-back-to-life-a-cryobiologist-explains-69500

Discover Magazine on Cryonics: https://www.discovermagazine.com/technology/will-cryonically-frozen-bodies-ever-be-brought-back-to-life

BBC Science Focus: https://www.sciencefocus.com/the-human-body/freezing-brain-back-to-life

PMC: “Cryoprotectants and Extreme Freeze Tolerance in a Subarctic Population of the Wood Frog”: https://pmc.ncbi.nlm.nih.gov/articles/PMC4331536/

ScienceDirect – Ice Crystal Formation: https://www.sciencedirect.com/science/article/abs/pii/S0011224010000222

Wood frog freeze tolerance research: https://www.nature.com/articles/s41598-021-98073-4

Strengthening Your Defenses: Understanding and Improving Immune Health in Your Golden Years

By John Turley

On February 18, 2026

In Medicine

Getting older comes with plenty of perks—wisdom, perspective, maybe even a better appreciation for a quiet Sunday morning. But one thing that doesn’t improve with age is your immune system. If you’ve noticed that colds seem to hang on longer than they used to, or that recovering from illness takes more time, you’re not imagining things. The aging immune system undergoes real, measurable changes that can affect your health in significant ways.

Understanding Your Immune System

Think of your immune system as an incredibly sophisticated security network spread throughout your entire body. Unlike your heart or lungs, it’s not located in one place—according to the Mayo Clinic, your immune system is essentially a giant collection of cells that travel through your blood and tissues, constantly patrolling for anything that doesn’t belong.

Your immune defense operates on two levels. The first responders are part of what’s called the innate immune system. It begins with the skin and mucous membranes that act as a barrier. They are backed up by specialized cells—including macrophages, neutrophils, and natural killer cells that act like scouts, surveying your body for foreign particles like bacteria, viruses, or damaged cells. When they detect something foreign, they sound an alarm and start an immune response triggering inflammation, your body’s response to attack which causes swelling, redness, and heat at infection sites.

This is the signal for your second line of defense—your adaptive immune system—to begin a more specialized and sophisticated attack against the invaders. This system includes T cells that attack and kill infected cells and B cells that make antibodies. They learn to recognize specific pathogens and once they encounter a particular germ, they remember it. In the future, if you’re exposed to the same germ, your adaptive immune system will mount a more effective and swifter response. This is why you only get chickenpox once, and it’s the principle behind vaccination.

What Happens When the System Ages

Starting around your sixties, your immune system begins what scientists call immunosenescence—a gradual but significant decline in immune function. This isn’t just one simple change, but rather a cascade of alterations affecting both your innate and adaptive immune systems.

One of the most significant changes happens in your thymus, a small organ behind your breastbone that produces T cells. The process of involution involves significant structural thymic changes, including a reduction in size, a decrease in functional thymic tissue, and fatty replacement of the thymic parenchyma. As a result, you produce fewer fresh T cells to respond to new threats.

At the same time, something paradoxical happens: while your immune system becomes less effective at fighting infections, it also becomes more inflammatory. This chronic inflamed state contributes to biological aging and the development of age-related pathologies. Scientists call this “inflammaging”—chronic low-grade inflammation that persists throughout the body.

The practical consequences are significant. The immune system becomes slower to respond, which increases your risk of getting sick; it also means flu shots or other vaccines may not work as well or protect you for as long as expected. You’re also at higher risk for autoimmune disorders where your immune system mistakenly attacks healthy tissue. Wounds will heal more slowly.

Why Immune Function Declines

Multiple factors contribute to immune aging beyond just the passage of time. Chronic viral infections play a surprising role. Latent and chronic viral infections such as human cytomegalovirus (HCMV) and Epstein-Barr virus (EBV) affect the immune system and contribute to immunosenescence . These viruses lie dormant for years and when your immune system begins to age it is no longer able to effectively suppress them. They become active, and your immune system is put on perpetual alert, expressed as chronic inflammation, gradually wearing it down even further.

Your cells also undergo changes at the molecular level. With each cell division, the protective caps on your chromosomes called telomeres get shorter. Eventually, this limits your immune cells’ ability to divide and respond to threats. The shift in immune cell populations is dramatic—you have fewer naive cells ready to respond to new infections and more memory cells dedicated to past threats, which means you’re well-protected against diseases you’ve already had but vulnerable to new ones. Your immune army is continuing to prepare for the last war.

Chronic health conditions that become more common with age—diabetes, heart disease, kidney disease, chronic lung conditions—all accelerate immune aging. Even lifestyle factors like chronic stress, poor sleep, smoking, and excessive alcohol consumption take a heavier toll on your immune system as you age.

Strengthening Your Immune Defenses

The good news is that lifestyle interventions can meaningfully improve immune function in older adults. The evidence is particularly strong for several key strategies.

Physical Activity Makes a Real Difference

Exercise isn’t just about staying fit—it’s one of the most powerful immune boosters available. Regular exercise mitigates the aging processes of both the innate and adaptive immune system, particularly being associated with improved natural killer cell functioning. Studies comparing physically active older adults to sedentary ones consistently show better immune cell function in the active group.

The type and amount of exercise matters. Mayo Clinic recommends two strength training sessions and 150 minutes of moderate cardiovascular exercise weekly. But you don’t need to become a marathon runner—walking, swimming, cycling, yoga, and tai chi all provide significant benefits. Research shows that influenza vaccine responses are improved in active elderly populations, as demonstrated by higher antibody titers following 10 months of aerobic physical exercise.

The key is consistency and not overdoing it. Moderate, regular exercise strengthens your immune system, while extreme exercise can temporarily suppress it.

Nutrition: Fueling Your Immune Defense

What you eat directly impacts how well your immune system functions. The evidence supports focusing on whole, minimally processed foods rather than any specific “superfood” or restrictive diet. A balanced nutritious diet incorporating a variety of fruits and vegetables, whole grains, proteins, and probiotics positively impacts the immune system.

Several specific nutrients deserve attention. Protein becomes increasingly important with age because tryptophan, an essential amino acid found in protein-based foods including eggs, fish, dairy products, legumes, and meat, plays important roles in immune function. Omega-3 fatty acids from fish have anti-inflammatory properties that may help counter inflammaging.

The gut-immune connection is particularly important. Your gut contains roughly 70% of your immune system, and the bacteria living there directly influence immune function. Probiotic-rich foods like yogurt, sour cream and cottage cheese, some aged cheeses, and fermented vegetables (sauerkraut, some pickles) help maintain a healthy gut microbiome, which in turn supports immune health.

Certain vitamins and minerals play outsized roles in immune function. Vitamin D is crucial—it mediates immune function and regulation, strengthening of epithelial barriers and antioxidant defense. Unfortunately, it’s estimated that 95% of Americans don’t receive enough vitamin D from their diet alone, and nearly one-third have a vitamin D deficiency.

Zinc is another critical nutrient. Zinc exerts direct anti-viral effects and serves as a cofactor of dozens of proteins important for immune function and antioxidative defense, yet 15% of Americans are not meeting zinc needs from food alone and 30% of the world’s elderly population have a zinc deficiency.

Selenium, while needed in smaller amounts, is equally important. Selenium plays a role in anti-inflammatory, antiviral, and immune-cell activity and is useful in both innate and adaptive immunity through selenoproteins that partly reduce oxidative stress generated by viral pathogens.

Sleep: Your Immune System’s Recovery Time

Sleep isn’t just rest—it’s when your immune system does critical maintenance work. While you sleep, your body produces cytokines, a protein that helps regulate immune responses and fight off infections, and when you lack proper sleep, this decreases the amount of cytokines your body produces. The recommendation is clear: aim for seven to eight hours of quality, uninterrupted sleep per night.

Sleep quality matters as much as quantity. If you’re experiencing insomnia or sleep disruptions, addressing them should be a priority because poor sleep is linked not just to reduced immune function but also to increased risk of chronic diseases.

Stress Management and Social Connection

Chronic stress suppresses immune function in measurable ways. Finding effective stress management techniques—whether meditation, deep breathing, enjoyable hobbies, or time in nature—isn’t just about feeling better emotionally. These practices have real physiological effects on immune function.

Social connection matters more than you might think. Social isolation and loneliness are associated with increased inflammation and reduced immune function. Maintaining meaningful social connections, whether through family, friends, community groups, or religious organizations, appear to have genuine immune benefits.

Vaccination: Working With Your Immune System

Vaccines remain highly effective and are crucial for older adults. Vaccines introduce your immune system to viruses in a controlled manner, helping the adaptive immune system spot and neutralize germs more quickly. Staying current with recommended vaccines—including annual flu shots, pneumonia vaccines, RSV vaccines, shingles vaccines, and COVID-19 boosters—is one of the most effective ways to prevent serious illness.

The Supplement Question

While a balanced diet should be the foundation, supplements can fill genuine gaps, especially for nutrients like vitamin D that are difficult to obtain adequately from food alone. However, researchers still don’t know all the effects of lifestyle on the immune system, and there are no scientifically proven direct links between specific supplements and enhanced immune function in all contexts.

That said, if you’re deficient in specific nutrients, supplementation can help. Supplementation of higher dosages of vitamins D, C, and zinc may have positive effects during viral infections in deficient individuals. The key is working with your doctor to identify any actual deficiencies before starting supplements, because more isn’t always better, and some supplements can interact with medications.

Other Practical Steps

Some immune boosters are refreshingly simple. Hand washing remains one of the most effective ways to prevent infections. Staying hydrated helps your body flush out toxins and keeps immune cells functioning optimally. Not smoking—or quitting if you do—significantly improves immune function because smoking directly damages immune cells and increases inflammation. Excessive alcohol use also increases inflammation and is a significant source of free radicals.

Getting moderate sun exposure provides natural vitamin D while also offering stress-reduction benefits. Even 15-30 minutes of outdoor time daily can make a difference, though you need to balance sun exposure with skin cancer prevention.

Weight management can help prevent or reverse insulin resistance and metabolic syndrome reducing inflammation and slowing immunosenescence.

The Bottom Line

The aging immune system faces real challenges, but it’s far from helpless. While lifestyle changes don’t guarantee perfect immunity, every part of your body, including your immune system, functions better when protected from environmental assaults and bolstered by healthy-living strategies.

The most effective approach to an improved immune system combines multiple strategies: regular moderate exercise, a varied diet rich in whole foods with adequate protein and micronutrients, quality sleep, stress management, social connection, staying current with vaccinations, and addressing specific nutritional deficiencies through supplementation when needed. None of these interventions will turn back the clock, but together they can meaningfully improve immune resilience and your ability to fight off infections and recover from illness.

Illustration generated by author using Midjourney

Sources

National Center for Biotechnology Information – “Aging of the Immune System: Mechanisms and Therapeutic Targets”
https://pmc.ncbi.nlm.nih.gov/articles/PMC5291468/
MDPI Vaccines – “Immunosenescence: Aging and Immune System Decline”
https://www.mdpi.com/2076-393X/12/12/1314
Frontiers in Aging – “The 3 I’s of immunity and aging: immunosenescence, inflammaging, and immune resilience”
https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2024.1490302/full
Frontiers in Aging – “Immune Senescence, Immunosenescence and Aging”
https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2022.900028/full
National Center for Biotechnology Information – “Physical Activity and Diet Shape the Immune System during Aging”
https://pmc.ncbi.nlm.nih.gov/articles/PMC7146449/
National Center for Biotechnology Information – “Aging and the Immune System: the Impact of Immunosenescence on Viral Infection”
https://pmc.ncbi.nlm.nih.gov/articles/PMC6943173/
National Center for Biotechnology Information – “Physical Activity and Nutritional Influence on Immune Function”
https://pmc.ncbi.nlm.nih.gov/articles/PMC8531728/
National Center for Biotechnology Information – “Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids”
https://pmc.ncbi.nlm.nih.gov/articles/PMC7415215/
National Center for Biotechnology Information – “Nutritional risk of vitamin D, vitamin C, zinc, and selenium deficiency on COVID-19”
https://pmc.ncbi.nlm.nih.gov/articles/PMC8571905/

MedlinePlus Medical Encyclopedia – “Aging changes in immunity”
https://medlineplus.gov/ency/article/004008.htm
Mayo Clinic Press – “Aging and the immune system: Strengthening your body’s defenses”
https://mcpress.mayoclinic.org/healthy-aging/aging-and-the-immune-system/
Harvard Health Publishing – “How to boost your immune system”
https://www.health.harvard.edu/staying-healthy/how-to-boost-your-immune-system
Greater Good Health – “Understanding How Seniors Can Boost Their Immune Systems”
https://greatergoodhealth.com/patients/how-can-seniors-boost-their-immune-systems/
Nature Made – “Super D Immune Complex” (Nutritional information on vitamin D, zinc, and selenium)
https://www.naturemade.com/products/super-d-immune-complex

VO₂ Max Explained: The Fitness Metric That Predicts Health and Longevity

By John Turley

On February 11, 2026

In Medicine

If you’ve ever wondered what separates elite endurance athletes from weekend warriors—or why your friend can cruise up hills while you’re gasping for air—the answer often comes down to a vital sign you’ve probably never heard of — VO2 max. Think of it as your cardiovascular system’s horsepower rating, a number that tells you how efficiently your body can use oxygen during intense exercise.

What VO2 Max Actually Means

VO2 max stands for maximal oxygen consumption; it measures the maximum amount of oxygen your body can take in, transport, and use during exercise. Scientists express it in milliliters of oxygen per kilogram of body weight per minute (ml/kg/min). When you’re working out at your absolute limit—say, sprinting up a hill until you simply can’t go any faster—your muscles are burning through oxygen to produce energy. VO2 max represents the ceiling of that process, the point where your body has maxed out its oxygen delivery system and can’t use any more oxygen even if you try to push harder.

An average sedentary man might have a VO2 max around 30-40 ml/kg/min, while an average woman might measure 25-30 ml/kg/min. Elite endurance athletes, however, occupy an entirely different universe. Cross-country skiers and distance runners can reach values of 70-85 ml/kg/min or even higher. The legendary Norwegian cyclist Oskar Svendsen reportedly recorded a VO2 max of 97.5 ml/kg/min, which is probably the upper reaches of human cardiovascular capacity.

The rest of us are also affected by VO2 Max. In later life, it is closely tied to our everyday activities. There’s a minimum aerobic capacity required for independent living—walking briskly, climbing stairs, carrying groceries. As VO2 max declines to that functional threshold, small losses can translate into disproportionate declines in independence. Conversely, modest improvements can produce meaningful gains in stamina, balance, and confidence.

The Gold Standard of Measurement

The most accurate way to measure VO2 max involves what’s called a graded exercise test, typically performed in a lab or clinical setting. You’ll hop on a treadmill or stationary bike while wearing a mask connected to a metabolic cart—essentially a sophisticated machine that analyzes every breath you take. The test starts easy but gets progressively harder every few minutes. The technician increases either the speed, incline, or resistance while the equipment measures exactly how much oxygen you’re consuming and how much carbon dioxide you’re producing.

You keep going until you reach exhaustion—the point where you literally cannot continue despite maximum effort. The highest oxygen consumption rate recorded during this test is your VO2 max. It’s not a particularly pleasant experience, but it’s incredibly accurate. The test also provides valuable data about your anaerobic threshold, the point where your body starts relying more heavily on systems that don’t require oxygen and where lactic acid begins accumulating in your muscles.

For those of us without access to exercise labs, there are several field tests we can use to estimate VO2 max reasonably well. The Cooper test, developed by Dr. Kenneth Cooper in the 1960s, involves running as far as you can in 12 minutes on a track (that wouldn’t be too far for me). The distance you cover correlates with your VO2 max through established formulas [VO2max: (distance covered in meters – 504.9) / 44.73 = VO2 max in ml/kg/min]. Age and gender normed values can be found on a number of fitness websites. Many fitness watches and apps now offer VO2 max estimates based on heart rate data during runs, though these are less precise than laboratory testing.

Why This Number Matters

VO2 max serves as one of our strongest predictors of cardiovascular health and longevity. Research published in major medical journals has consistently shown that higher VO2 max values correlate with lower risks of heart disease, diabetes, and all-cause mortality. A 2018 study in the Journal of the American Medical Association (JAMA) that followed over 122,000 patients found that cardiorespiratory fitness (measured by VO2 max) was a better predictor of mortality than traditional risk factors like hypertension, diabetes, or even smoking.

The relationship is striking, for every 3.5 ml/kg/min increase in VO2 max, mortality risk drops by about 13 percent. People in the lowest fitness category (those with the poorest VO2 max scores) have death rates two to three times higher than those in the highest fitness category, even when controlling for other health factors.

Beyond mortality statistics, VO2 max influences your daily quality of life. A higher VO2 max means your heart doesn’t have to work as hard during routine activities. Climbing stairs, carrying groceries, playing with kids or grandkids—all these activities demand less relative effort when your cardiovascular system operates efficiently. Your body becomes better at delivering oxygen-rich blood to working muscles and clearing away metabolic waste products, which means you fatigue less easily and recover more quickly.

The Path to Improvement

The encouraging news is that VO2 max responds remarkably well to training, especially if you’re starting from a sedentary baseline. You can’t completely escape genetics—some people are simply born with larger hearts, more efficient lungs, or a higher percentage of slow-twitch muscle fibers—but training can typically improve VO2 max by 15-30 percent in previously untrained people.

The most effective approach combines several training methods. High-intensity interval training (HIIT) has emerged as particularly powerful tool for boosting VO2 max. These workouts involve short bursts of near-maximal effort followed by recovery periods. A classic protocol might involve running hard for four minutes at about 90-95 percent of your maximum heart rate, then recovering with light jogging for three minutes, repeated four or five times. Studies show that just two or three HIIT sessions per week can produce significant improvements in VO2 max within eight to twelve weeks.

Longer, steady-state aerobic exercise also plays a crucial role. These sessions—think longer runs at a conversational pace—improve your cardiovascular system’s efficiency and build the capillary networks that deliver oxygen to muscles. The optimal training program typically includes both high-intensity intervals and longer moderate-intensity sessions, along with adequate recovery time.

Interestingly, resistance training can indirectly support VO2 max improvements as well. While lifting weights won’t directly boost your oxygen consumption capacity the way running does, it helps maintain lean muscle mass, improves movement efficiency, and can enhance your ability to perform high-intensity cardiovascular work.

This high intensity training is all well and good for young, relatively healthy people. But what about older folks, particularly those with underlying medical problems?

The encouraging news: VO2 max responds to training well into our 70s, 80s, and beyond. Key approaches involve the same elements but tailored to age and medical history.

Moderate-intensity aerobic exercise (brisk walking, cycling, swimming) performed most days of the week is the primary element. Individually adjusted interval training, including carefully supervised higher intensity intervals, have shown impressive VO2 max gains even in older populations. Strength training is beneficial for older folks as well, and as an added benefit, it helps maintain and even improve bone density. A personal trainer can help design your fitness program to maximize improvement while minimizing the likelihood of injury.

Stop any exercise immediately if you experience chest pain, dizziness, or extreme shortness of breath. Remember consistency matters more than intensity alone and, most importantly, never start any exercise program without checking with your doctor first.

The Inevitable Decline

Here’s the less cheerful part: VO2 max naturally declines with age, typically dropping about 10 percent per decade after age 30 in sedentary people. This decline accelerates after age 70. However—and this is crucial—regular exercise dramatically slows this process. Senior athletes who maintain consistent training can preserve VO2 max values that rival or exceed those of sedentary people decades younger. A fit 60-year-old can easily have a higher VO2 max than an inactive 40-year-old.

The decline happens for several reasons: maximum heart rate decreases, cardiac output drops, muscle mass decreases, and the body becomes less efficient at extracting oxygen from blood. But none of these changes are inevitable consequences of aging alone—they’re heavily influenced by activity levels.

Putting It in Perspective

While VO2 max provides valuable information about cardiovascular fitness, it’s worth remembering that it’s just one metric among many. You don’t need the VO2 max of an Olympic athlete to be healthy and enjoy an active life (thankfully). A moderate VO2 max maintained consistently into your later years will serve you far better than a high value in your twenties followed by decades of inactivity.

The real value of understanding VO2 max lies in what it represents: your body’s fundamental capacity to generate energy and support movement. When you work to improve this capacity through regular cardiovascular exercise, you’re investing in both your current quality of life and your long-term health prospects. Every little bit helps—so put down the remote, get up off the couch and start walking. You’ll be glad you did.

Sources:

American College of Sports Medicine on VO2 max testing: https://www.acsm.org/
Mayo Clinic on cardiorespiratory fitness: https://www.mayoclinic.org/
National Institutes of Health research on fitness and mortality: https://www.nih.gov/
JAMA Network 2018 study on cardiorespiratory fitness and mortality: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2707428

Image generated by author using ChatGPT

Fecal Microbiota Transplantation: When Waste Becomes Therapy

By John Turley

On February 4, 2026

In Medicine

Today I’m going to talk about something that may sound unbelievable and maybe even a little gross—fecal transplant. Yes, it’s exactly what it sounds like. Getting a transplant of someone else’s poop.

The human gut contains trillions of microorganisms—bacteria, viruses, fungi—living in a complex ecosystem that influences everything from digestion to immune function. This is called the microbiome. When this ecosystem gets disrupted, the consequences can range from uncomfortable to life-threatening. Enter one of medicine’s most counterintuitive treatments: fecal microbiota transplantation, or FMT, where stool from a healthy donor is transferred to a patient to restore a healthy community of gut microbes.

What Is FMT

The basic idea is simple: if someone’s microbiome has been badly disrupted (most commonly by repeated antibiotic exposure), replacing it with a balanced microbial ecosystem can help the gut recover. At its core, FMT is taking fecal matter from a healthy donor and introducing it into a patient’s gastrointestinal tract. But it’s not the solid waste itself that matters; it’s the billions of beneficial bacteria and other microorganisms living in that material. Think of it as a probiotic treatment on steroids, delivering an entire functioning ecosystem rather than just a few select bacterial strains.

The gut microbiome plays crucial roles in digestion, vitamin production, immune system regulation, and even protection against harmful pathogens. When antibiotics, illness, or other factors devastate this ecosystem, dangerous bacteria like Clostridioides difficile (C. diff) can take over, causing severe diarrhea, inflammation, and potentially fatal infections.

The Clinical Track Record

While it may sound like “weird science”, FMT has been around for centuries. It was used in ancient Chinese medicine in a formulation called “yellow soup“ to treat food poisoning and intractable diarrhea. It was used as early as the 16th century in Europe to treat sick farm animals, particularly sheep and cattle.

FMT’s most dramatic success story involves C. diff infections, particularly the recurrent cases that don’t respond to antibiotics. Multiple randomized controlled trials have shown FMT to be remarkably effective—with cure rates often exceeding 80-90% for recurrent C. diff infections, compared to roughly 25-30% for continued antibiotic therapy. A landmark 2013 study reported in the New England Journal of Medicine was stopped early because FMT was so dramatically superior to standard treatment that continuing to withhold it from the control group seemed unethical.

Beyond C. diff, researchers are investigating FMT for inflammatory bowel diseases like ulcerative colitis and Crohn’s disease, with mixed but occasionally promising results. Some studies have shown potential for ulcerative colitis, with remission rates around 24-27%. The research into Crohn’s disease, irritable bowel syndrome, metabolic disorders, and even neurological conditions is ongoing but less conclusive. The FDA currently considers FMT an investigational treatment for most conditions except recurrent C. diff, where it’s become a recognized therapeutic option.

How It Works

The actual process of FMT can use several routes. The most common approaches involve colonoscopy, where the donated material is delivered directly to the colon, or through nasogastric or nasoduodenal tubes that thread through the nose down to the small intestine. More recently, oral capsules containing frozen, encapsulated donor stool have become available, offering a less invasive alternative that patients often prefer.

Before the transplant, the donated stool is carefully processed. It’s typically mixed with a saline solution and filtered to remove large particles while preserving the microbial communities. The resulting liquid suspension is what gets delivered to the patient. For frozen preparations, this material is mixed with a cryoprotectant, frozen at extremely cold temperatures, and can be stored for months before use.

The preparation isn’t just about the donor material—patients often undergo their own preparation. Many protocols include antibiotics to reduce the overgrowth of harmful bacteria before the transplant, followed by bowel cleansing similar to what you’d do before a colonoscopy. The idea is to create a relatively clean slate where the new microbial ecosystem can establish itself.

Sources of Donor Material

This brings us to one of the most critical aspects: donor selection and screening. Not just anyone can donate stool for medical use. The screening process is extensive and rigorous, rivaling or exceeding the scrutiny applied to blood donation.

Donors undergo detailed health questionnaires covering everything from recent travel and antibiotic use to gastrointestinal symptoms and risk factors for infectious diseases. They provide blood and stool samples that are tested for a long list of potential pathogens: C. diff, Helicobacter pylori, parasites, hepatitis A, B, and C, HIV, syphilis, and various other bacteria and viruses. The FDA issued guidance requiring additional testing for multi-drug resistant organisms after several patients contracted serious infections from FMT.

Donors generally fall into two categories: directed donors and universal donors. Directed donors are typically family members or friends who undergo screening and provide stool specifically for one patient. Universal donors go through the same rigorous screening but provide samples that can be used for multiple patients. These universal donors often work with stool banks—specialized facilities that collect, process, screen, and distribute donor material to healthcare providers.

The largest stool bank in the United States, OpenBiome, was founded in 2012 and has processed material from thousands of donors for tens of thousands of treatments. They report that only about 2-3% of volunteer donors successfully make it through the screening process, highlighting just how selective the criteria are. These banks have made FMT more widely available, eliminating the need for individual healthcare facilities to find and screen their own donors.

The Balance of Promise and Caution

While FMT represents a genuine breakthrough for recurrent C. diff infections, the medical community remains appropriately cautious about expanding its use. The FDA regulates FMT and has expressed concerns about potential risks, particularly after cases where patients developed serious infections from inadequately screened donors. There questions about the long-term effects of introducing another person’s microbiome, and there are theoretical concerns about transmitting conditions or predispositions we don’t fully understand.

The research into FMT for conditions beyond C. diff continues, but many trials have shown modest or inconsistent results. The microbiome’s role in health and disease is incredibly complex, and what works dramatically for one condition may not translate to others. Still, the fundamental insight—that our gut microbiome profoundly influences our health and that we can therapeutically manipulate it—has opened potential new avenues in medicine.

Sources

1. van Nood, E., et al. (2013). “Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile.” New England Journal of Medicine, 368(5), 407-415. https://www.nejm.org/doi/full/10.1056/NEJMoa1205037

2. U.S. Food and Drug Administration. “Fecal Microbiota for Transplantation: Safety Information.” https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fecal-microbiota-transplantation-safety-information

3. Cammarota, G., et al. (2017). “European consensus conference on faecal microbiota transplantation in clinical practice.” Gut, 66(4), 569-580. https://gut.bmj.com/content/66/4/569

4. Moayyedi, P., et al. (2015). “Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.” Gastroenterology, 149(1), 102-109. https://www.gastrojournal.org/article/S0016-5085(15)00381-5/fulltext

5. Kelly, C.R., et al. (2016). “Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.” Gastroenterology, 150(1), 276-290. https://www.gastrojournal.org/article/S0016-5085(15)01626-7/fulltext

6. OpenBiome. “Our Process: Screening.” https://www.openbiome.org/safety

7. Quraishi, M.N., et al. (2017). “Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.” Alimentary Pharmacology & Therapeutics, 46(5), 479-493. https://onlinelibrary.wiley.com/doi/full/10.1111/apt.14201

Illustration generated by author using Midjourney

The Price Tag Mystery: Why Nobody Really Knows What Healthcare Costs in America

By John Turley

On January 29, 2026

In Commentary, Medicine, Politics

Imagine walking into a store where nothing has a price tag. When you get to the register, the cashier scans your items and tells you the total—but that total is different for every customer. Your neighbor might pay $50 for the same items that cost you $200. The store won’t tell you why, and you won’t find out until after you’ve already “bought” everything.

Welcome to American healthcare, where the simple question “how much does this cost?” has no simple answer.

You might think I’m exaggerating, but the evidence suggests otherwise. Research published in late 2023 by PatientRightsAdvocate.org found that prices for the same medical procedure can vary by more than 10 times within a single hospital depending on which insurance plan you have, and by as much as 33 times across different hospitals. A knee replacement that costs around $23,170 in Baltimore might run $58,193 in New York. An emergency department visit that one facility charges $486 for might cost $3,549 at another hospital for the identical service.

The fundamental problem is that hospitals and doctors don’t have one price for their services. They have dozens, sometimes hundreds, of different prices for the exact same procedure depending on who’s paying. This bizarre system evolved because most healthcare in America isn’t a simple transaction between patient and provider—there’s a third party in the middle called an insurance company, and that changes everything.

The Fiction of Chargemaster Prices

A hospital chargemaster is essentially the hospital’s internal price list—a massive catalog that assigns a dollar amount to every service, supply, test, medication, and procedure the hospital can bill for, from an aspirin to a complex surgery. These listed prices are usually very high and are not what most patients actually pay; instead, the chargemaster functions as a starting point for negotiations with insurers and government programs like Medicare and Medicaid, which typically pay much lower, pre-set rates. What an individual patient ultimately pays depends on several factors layered on top of the chargemaster price. Think of them like the manufacturer’s suggested retail price on a car: technically real, but nobody pays them.

A hospital might list an MRI at $3,000 or a blood test at $500. But then insurance companies come in. They represent thousands or millions of potential patients, which gives them serious bargaining power. They negotiate with hospitals along these lines: “We’ll send you lots of patients, but only if you give us a discount.” So, the hospital agrees to accept much less—maybe they’ll take $1,200 for that $3,000 MRI or $150 for the blood test. This discounted amount is called the “negotiated rate,” and it’s what the insurance company will really pay.

Here’s where it gets messy: every insurance company negotiates its own rates with every hospital. Blue Cross might negotiate one price, Aetna a different price, UnitedHealthcare yet another. The same exact MRI at the same hospital might be $1,200 for one insurer’s customers and $1,800 for another’s. And these negotiated rates have traditionally been kept secret—treated like confidential business information that gives each party a competitive advantage.

The Write-Off Game

What happens to that difference between the chargemaster price and the negotiated rate? The hospital “writes it off.” That’s accounting language for “we accept that we’re not getting paid this money, and we’re taking it off the books.” If the hospital charged $3,000 but agreed to accept $1,200, they write off $1,800. This isn’t lost money in the normal sense—they never expected to collect it in the first place. The chargemaster prices are inflated specifically because everyone knows discounts are coming. Some hospitals now post “discounted cash prices” that are often far below chargemaster and sometimes even below some negotiated rates. These are sometimes, though not always, offered to uninsured patients, generally referred to as self-pay. There can be a catch—some hospitals require lump-sum payment of the total bill to qualify for the lower price.

According to the American Hospital Association, U.S. hospitals collectively plan to write off approximately $760 billion in billed charges in 2025 across all categories of write-offs. That’s not a typo—$760 billion. These write-offs happen in several different situations. The most common are contractual write-offs, where the provider has agreed to accept less than their list price from insurance companies.

Hospitals have far more write-offs than just contractual. They also write off money for charity care—treating patients who can’t afford to pay anything, and they write off bad debt when patients could pay but don’t. They write off small balances that aren’t worth the administrative cost of collection, and they write off amounts related to various billing errors, denied claims, and coverage disputes. Healthcare providers typically adjust about 10 to 12 percent of their gross revenue due to these various write-offs and claim adjustments.

Why Such Wild Variation?

Even with all these negotiated discounts built into the system, the prices still vary enormously. A 2024 study from the Baker Institute found that for emergency department visits, the price charged by hospitals in the top 10% can be three to seven times higher than the hospitals in the bottom 10% for the identical procedure. Research published in Health Affairs Scholar in early 2025 found that even after adjusting for differences between insurers and procedures, the top 25% of prices across all states is 48 percent higher than the bottom 25% of prices for inpatient services.

Several factors drive this variation. Hospitals in areas with less competition can charge more because insurers have fewer alternatives for negotiation. Prestigious hospitals can demand higher rates because insurers want them in their networks to attract customers. Some insurance companies have more bargaining power than others based on their market share. There’s no central authority setting prices—it’s all private negotiations, hospital by hospital, insurer by insurer, procedure by procedure.

For patients, this creates a nightmare scenario. Even if you have insurance, you usually have no idea what you’ll pay until after you’ve received care. Your out-of-pocket costs depend on your deductible (the amount you pay before insurance kicks in), your copay or coinsurance (your share after insurance starts paying), and whether the negotiated rate between your specific insurance and that specific hospital is high or low. Two people with different insurance plans getting the same procedure at the same hospital on the same day can end up with drastically different bills.

Research using new transparency data confirms this isn’t just anecdotal. A study from early 2025 found that for something as routine as a common office visit, mean prices ranged from $82 with Aetna to $115 with UnitedHealth. Within individual insurance companies, the price of the top 25% of office visits was 20 to 50 percent higher than the bottom 25%, meaning even within one insurer’s network, where you go or where you live makes a huge difference.

The Government Steps In

The federal government finally said “enough” and started requiring transparency. Since 2021, hospitals must post their prices online, including what they’ve negotiated with each insurance company. The Centers for Medicare and Medicaid Services (CMS) strengthened these requirements in 2024, mandating standardized formats and increasing enforcement. Health insurance plans face similar requirements to disclose their negotiated rates.

The theory was straightforward: if patients could see prices ahead of time, they could shop around, which would force prices down through competition. CMS estimated this could save as much as $80 billion by 2025. The idea seemed sound—transparency works in other markets, so why not healthcare?

In practice, it’s been messy. A Government Accountability Office (GAO) report from October 2024 found that while hospitals are posting data, stakeholders like health plans and employers have raised serious concerns about data quality. They’ve encountered inconsistent file formats, extremely complex pricing structures, and data that appears to be incomplete or possibly inaccurate. Even when hospitals post the required information, it’s often so convoluted that comparing prices across facilities becomes nearly impossible for average consumers.

An Office of Inspector General report from November 2024 found that not all selected hospitals were complying with the transparency requirements in the first place. And CMS still doesn’t have robust mechanisms to verify whether the data being posted is accurate and complete. The GAO recommended that CMS assess whether hospital pricing data are sufficiently complete and accurate to be usable, and to assess if additional enforcement if needed.

Imagine trying to comparison shop when one store lists prices in dollars, another in euros, and a third uses a proprietary currency they invented. That’s roughly where we are with healthcare price data—technically available, but practically unusable for most people trying to make informed decisions.

The Trump administration in 2025 signed a new executive order aimed at strengthening enforcement of price transparency rules and directing agencies to standardize and make hospital and insurer pricing information more accessible; this action built on rather than reduced the earlier requirements. Hopefully this will improve the ability of patients to access real costs, but it is my opinion that the industry will continue to resist full and open compliance.

The Limits of Shopping for Healthcare

There’s also a deeper philosophical problem: for healthcare to work like a normal market where price transparency drives competition, patients would need to be able to shop around based on price. That could work for scheduled procedures like knee replacements, colonoscopies, or elective surgeries. You have time to research, compare, and choose.

But it doesn’t work at all when you’re having a heart attack, or your child breaks their arm. You go to the nearest hospital, period. You’re not calling around asking about prices while someone’s having a medical emergency. Even for non-emergencies, choosing based on price assumes equal quality across providers, which isn’t always true and is even harder to assess than price itself.

A study on price transparency tools found mixed results on whether they truly reduce spending. Some research shows modest savings when people use price comparison tools for shoppable services like imaging and lab work. But utilization of these tools remains low, and for many healthcare encounters, price shopping simply isn’t practical or appropriate.

Who Really Knows?

So, who truly understands what things cost in this system? Hospital administrators know what different insurers pay them for specific procedures, but that knowledge is limited to their facility. They don’t necessarily know what other hospitals charge. Insurance company executives know what they’ve negotiated with various hospitals in their network, but they haven’t historically shared meaningful price information with their customers in advance. And they don’t know what their competitors have negotiated.

Patients, caught in the middle, often find out their costs only when they receive a bill weeks after treatment. By that point, the care has been delivered, and the financial damage is done. Recent surveys suggest that surprise medical bills remain a significant problem, with many patients receiving unexpected charges from out-of-network providers they didn’t choose or even know were involved in their care.

The people who are starting to get a comprehensive view are researchers and policymakers analyzing the newly available transparency data. Studies published in 2024 and 2025 using these data have given us unprecedented visibility into pricing patterns and variation. But this is aggregate, statistical knowledge—it helps us understand the system but doesn’t necessarily help individual patients figure out what they’ll pay for a specific procedure.

Where We Stand

The transparency regulations represent a genuine attempt to inject some market discipline into healthcare pricing. Making negotiated rates public breaks down the information asymmetry that has allowed prices to vary so wildly. In theory, if patients and employers can see that Hospital A charges twice what Hospital B does for the same procedure, competitive pressure should push prices toward the lower end.

There’s some early evidence this might be working. A study of children’s hospitals found that price variation for common imaging procedures decreased by about 19 percent between 2023 and 2024, though overall prices continued rising. Whether this trend will continue and expand to other types of facilities remains to be seen. I am concerned that rather than lowering overall prices it may cause hospitals at the lower end to raise their prices closer to those at the higher end.

Significant obstacles remain. The data quality issues need resolution before the information becomes truly usable. Many patients lack either the time, expertise, or practical ability to shop based on price. And the fundamental structure of American healthcare—with its complex interplay of providers, insurers, pharmacy benefit managers, and government programs—means that even perfect price transparency won’t create a simple, straightforward market.

So, to return to the original question: does anyone truly know the cost of medical care in the United States? In an aggregate sense, researchers and policymakers are starting to understand the patterns thanks to transparency requirements. The data are revealing just how variable and opaque pricing has been. But as a practical matter for individual patients trying to figure out what they’ll pay for needed care, not really. The information is becoming available but remains largely inaccessible or incomprehensible for ordinary people trying to make informed healthcare decisions.

The $760 billion in annual write-offs tells you everything you need to know: the posted prices are largely fictional, the negotiated prices vary wildly, and the system has evolved to be so complex that even the people operating within it struggle to understand the full picture. We’re making progress toward transparency, but we’re a long way from a healthcare system where patients can confidently get the answer to the simple question: “How much will this cost?”

A closing thought: All of this could be solved by development of a single-payer healthcare system such as I proposed in my previous post America’s Healthcare Paradox: Why We Pay Double and Get Less.

Centers for Medicare & Medicaid Services, Hospital Price Transparency Fact Sheet: https://www.cms.gov/newsroom/fact-sheets/hospital-price-transparency-fact-sheet
U.S. Government Accountability Office, “Health Care Transparency: CMS Needs More Information on Hospital Pricing Data Completeness and Accuracy” (October 2024): https://www.gao.gov/products/gao-25-106995
PatientRightsAdvocate.org, Price Variation Report (December 2023): https://www.patientrightsadvocate.org/blog/new-report-highlights-extreme-price-variation-for-the-same-medical-procedures-within-and-across-hospitalsnbspnbsp
Baker Institute for Public Policy, “Prices Versus Costs: Unpacking Rising US Hospital Profits” (September 2024): https://www.bakerinstitute.org/research/prices-versus-costs-unpacking-rising-us-hospital-profits
Health Affairs Scholar, “Understanding health care price variation: evidence from Transparency-in-Coverage data” (February 2025): https://academic.oup.com/healthaffairsscholar/article/3/2/qxaf011/7965202
U.S. Department of Health and Human Services Office of Inspector General, “Not All Selected Hospitals Complied With the Hospital Price Transparency Rule” (November 2024): https://oig.hhs.gov/reports/all/2024/not-all-selected-hospitals-complied-with-the-hospital-price-transparency-rule/
BellMedEx, “What is a Provider Write-Off? Understanding When and How to Write Off a Claim” (March 2025): https://bellmedex.com/provider-write-off-claim-meaning/
Peterson-KFF Health System Tracker, “Price transparency and variation in U.S. health services” (June 2022): https://www.healthsystemtracker.org/brief/price-transparency-and-variation-in-u-s-health-services/

Hepatitis B Vaccine: Three Shots and You’re Done for Life?

By John Turley

On January 28, 2026

In Medicine

If you’re trying to figure out whether you need a hepatitis B vaccine or wondering if the one you got years ago is still protecting you, you’re not alone. The hepatitis B vaccine is one of those medical interventions that raises straightforward questions: How many shots do you need? And does it really last forever? I thought I should follow up last week’s general discussion of hepatitis with some specifics on this vaccine.

The Shot Schedule

The traditional hepatitis B vaccine series requires three shots spaced over six months. You get the first dose, then return for a second shot one to two months later and finally complete the series with a third dose at the six-month mark. There is also a combination hepatitis A and B vaccine that follows the same schedule. This schedule has been the standard for decades and works well for both children and adults.

But here’s something newer: In 2017, the FDA approved a two-dose hepatitis B vaccine called Heplisav-B for adults 18 and older. With this option, you only need two shots spaced one month apart. For parents of young children, there is Pediarix, a combination vaccine that bundles hepatitis B protection with vaccines for other diseases, streamlining the infant immunization schedule.

Does It Really Last a Lifetime?

This is where the science gets interesting. The short answer is yes, for most people the protection appears to be lifelong. But the mechanism behind this is more nuanced than you might expect.

After you complete the vaccine series, your body produces antibodies against hepatitis B. Over time—sometimes after just a few years—the level of these antibodies in your blood can decline to the point where they’re barely detectable or even undetectable. On the surface, that sounds concerning. But here’s the key: your immune system has memory.

Even when antibody levels drop, your body retains specialized immune cells that “remember” hepatitis B. If you encounter the virus years or decades later, these memory cells spring into action, rapidly producing new antibodies to fight off the infection before it can establish itself. Researchers have followed vaccinated individuals for more than 30 years and found that this immune memory remains protective even when blood tests show low antibody levels.

Who Might Need a Booster?

For most people with healthy immune systems, the CDC doesn’t recommend booster shots. Once you’ve completed the series and your body has responded appropriately, you’re considered protected. However, there are exceptions. People with compromised immune systems—such as those undergoing dialysis, living with HIV, or taking immunosuppressive medications—may need periodic booster doses. These individuals should work with their healthcare providers to monitor their antibody levels and determine if additional shots are necessary.

The Bottom Line

The hepatitis B vaccine is a three-shot series (or two shots with the newer formulation) that provides protection that researchers believe lasts a lifetime for most people. While your antibody levels might decline over the years, your immune system’s memory keeps you safe. It’s one of those rare cases where you can check something off your health to-do list and genuinely move on.

Sources:

CDC Hepatitis B Vaccination: https://www.cdc.gov/hepatitis/hbv/vaccineadults.htm
FDA Vaccines Information: https://www.fda.gov/vaccines-blood-biologics/vaccines/heplisav-b

Understanding Hepatitis: A Guide to Types A, B, and C

By John Turley

On January 21, 2026

In Medicine

If you’ve heard of hepatitis, you probably know it has something to do with the liver. But there’s a whole family of hepatitis viruses, each with its own personality when it comes to how it spreads, what it does to your body, and how we can prevent or treat it. Let’s walk through the three most common types—hepatitis A, B, and C—and then dive into a controversy that’s making headlines right now: the hepatitis B vaccine.

What Is Hepatitis, Anyway?

At its core, hepatitis just means inflammation of the liver. Your liver is a workhorse organ that filters toxins, produces essential proteins like albumin, processes amino acids, and stores energy. When a hepatitis virus attacks it, the inflammation can range from a minor inconvenience to a life-threatening condition. The three main culprits—hepatitis A, B, and C viruses—are completely different organisms that just happen to target the same organ.

Hepatitis A: The Food and Water Troublemaker

Hepatitis A is often called “traveler’s hepatitis” because it spreads through food and water that are contaminated with fecal matter. Think of it as the virus you might pick up from eating unwashed produce, drinking contaminated water, or consuming raw shellfish from polluted waters. Other risk factors include unprotected sex and IV drug use. According to the CDC, there were an estimated 3,300 acute infections in 2023 in the United States.

The good news about hepatitis A is that it typically heals itself within 2 months. When symptoms appear—which take about 15 to 50 days after infection—they can include jaundice (that yellowing of the skin and eyes), fever, fatigue, nausea, and dark urine. Many young children don’t show any symptoms at all. The virus doesn’t become chronic, and once you’ve had it, your body produces antibodies that protect you for life.

Prevention is straightforward: there’s a safe and effective vaccine, and basic hygiene goes a long way. Wash your hands thoroughly, especially after using the bathroom and before preparing food. When traveling to areas with questionable water quality, stick to bottled or boiled water and avoid washing raw food in local water.

Treatment is mostly supportive—rest, fluids, and time. Your liver does the healing work itself.

Hepatitis B: The Blood and Body Fluid Virus

Hepatitis B is where things get more serious. This virus spreads through blood and other body fluids, which means it can be transmitted through sexual contact, sharing needles, or from mother to baby during childbirth. Healthcare workers are especially at risk from needle sticks and sharps injuries. It’s a highly infectious and tough virus that can live on surfaces for up to a week. Even tiny amounts of dried blood on seemingly innocent things like razors, nail clippers, or toothbrushes can potentially spread the infection.

According to the CDC, there were an estimated 14,400 acute infections in 2023, Approximately 640,000 adults were living with chronic hepatitis B during the 2017-2020 period and that’s what makes it particularly concerning: while the hepatitis B virus often causes short-term illness, it can become chronic.

The incubation period is long—typically 90 days with a range of 60 to 150 days. When symptoms do appear, they mirror hepatitis A: jaundice, fatigue, abdominal pain, nausea, and dark urine. But here’s the frightening part: most young children and many adults show no symptoms at all, meaning they can spread the virus without knowing they’re infected.

The chronic infection risk varies dramatically by age. If you’re infected as a newborn, you have a 90% chance of developing chronic hepatitis B. For adults, the risk drops to under 5%. Those with chronic infection face serious long-term consequences—15% to 25% of people with chronic infection develop serious liver disease, including cirrhosis, liver failure, or liver cancer.

Treatment for acute hepatitis B is supportive, but several antiviral medications are available for people with chronic infection. These don’t completely eradicate the disease but produce a “functional cure” that significantly slows liver damage and reduces complications.

Prevention is critical. There’s a highly effective vaccine—we’ll talk more about the controversy surrounding it in a moment. Avoiding exposure to infected blood and body fluids is essential. This means safe sex practices, never sharing needles or personal care items that might have blood on them, and ensuring proper sterilization of medical and tattooing equipment.

Hepatitis C: The Silent Epidemic

Hepatitis C is transmitted primarily through blood-to-blood contact. The most common route is sharing needles among people who inject drugs, though it can also spread through contaminated medical equipment, and rarely through sexual contact. Mother-to-child transmission during childbirth is possible but uncommon. Screening of blood products has made transfusion related infections rare. About 10% of cases have no identified source.

What makes hepatitis C insidious is its stealthy nature. Many people with hepatitis C don’t have symptoms, and acute hepatitis with jaundice is rare, occurring in only about 10% of infections. The symptoms that do appear—fatigue, mild flu-like feelings—are easily dismissed. Meanwhile, the majority of people (60-70%) develop chronic infection. I recommend a screening blood test at least once for all adults over age 55, as they are the group most likely to have hepatitis C without an identifiable source.

The incubation period ranges widely, from 2 weeks to 6 months, typically 6 to 9 weeks. Without treatment, chronic hepatitis C can lead to cirrhosis and liver cancer over decades. Before modern treatments, it was a leading cause of liver transplants.

Treatment for hepatitis C has undergone a revolution. The old approach—interferon injections combined with ribavirin—had terrible side effects and worked in only about half of patients. Today, we have direct-acting antivirals (DAAs), which can cure more than 95% of cases with just 8-12 weeks of well-tolerated oral medication. These drugs target specific proteins the virus needs to replicate, essentially starving it out of existence. The treatment is so effective that hepatitis C is now considered a curable disease.

Prevention focuses on avoiding blood-to-blood contact. Never share needles, syringes, or any drug equipment. If you’re getting a tattoo or piercing, ensure the facility follows proper sterilization procedures. Healthcare workers should follow standard precautions with blood and body fluids. Unfortunately, there’s no vaccine for hepatitis C yet, though researchers continue working on one.

The Hepatitis B Vaccine Controversy: What’s Really Happening

Now let’s address the elephant in the room—the recent controversy over the hepatitis B vaccine for newborns. This topic exploded in the news in December 2025, and it’s worth understanding what’s currently going on versus what the science says.

The Recent Development

On December 5, 2025, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted 8-3 to recommend hepatitis B vaccination at birth only for infants born to mothers who test positive for the virus or whose status is unknown. This reverses decades of policy that recommended universal hepatitis B vaccination for all newborns within 24 hours of birth.

The Arguments For Changing the Policy

Some ACIP members raised concerns about vaccine safety and parental hesitancy. Committee member Retsef Levi heralded the move as “a fundamental change in the approach to this vaccine,” which would encourage parents to “carefully think about whether they want to take the risk of giving another vaccine to their child”. The controversy includes historical concerns about possible links between the hepatitis B vaccine and conditions like multiple sclerosis, autism, and other autoimmune disorders.

What Science Actually Shows

The evidence on vaccine safety is quite robust. Concerns about multiple sclerosis emerged in France in the 1990s. Since then, a large body of scientific evidence shows that hepatitis B vaccination does not cause or worsen MS. The World Health Organization’s Global Advisory Committee on Vaccine Safety has concluded there is no association between the hepatitis B vaccine and MS. It is one of the safest vaccines studied.

As for other safety concerns, CDC reviewed VAERS reports from 2005-2015 and found no new or unexpected safety concerns. The most common side effects are minor: soreness at the injection site, headache, and fatigue lasting 1-2 days.

Why the Universal Birth Dose Matters

The scientific and medical communities have strongly opposed this policy change. The American Academy of Pediatrics states that from 2011-2019, rates of reported acute hepatitis B remained low among children and adolescents, likely explained in part by the implementation of childhood hepatitis B vaccine recommendations published in 1991.

Here’s why newborns are so vulnerable: infected infants have a 90% chance of developing chronic hepatitis B, and a quarter of those will die prematurely from liver disease when they become adults.

The “just target high-risk babies” approach has a major flaw: the CDC estimates about 640,000 adults have chronic hepatitis B, but about half don’t know they’re infected. Before universal vaccination, about half of infected children under 10 got it from their mothers—the rest contracted it through other exposures not identified by maternal screening.

The Global Context

Claims that the U.S. is an outlier don’t hold up. As of September 2025, 116 of 194 WHO member states recommend universal hepatitis B birth dose vaccination. European countries that do not recommend a universal birth dose have a much lower hepatitis B incidence rate and more robust antenatal maternal screening. The majority still recommend vaccination at two to three months.

The Bottom Line

All three types of hepatitis pose serious health risks, but we have powerful tools to prevent and treat them. Hepatitis A and B have safe, effective vaccines that have dramatically reduced disease rates. Hepatitis C, while lacking a vaccine, is now curable with modern antiviral medications.

The hepatitis B vaccine controversy highlights a broader tension in public health: balancing individual autonomy with community protection. The scientific evidence strongly supports the vaccine’s safety and the effectiveness of universal newborn vaccination in preventing a disease that can be fatal. Multiple studies, decades of safety data, and recommendations from medical organizations worldwide back this up.

For parents making decisions about their newborns, the facts are these: hepatitis B is a serious disease with a high risk of becoming chronic in infants, the vaccine is highly effective at preventing infection, and extensive safety monitoring has found it to be safe with only minor, temporary side effects. As hepatitis research continues, we’re seeing remarkable progress—from the near-eradication of hepatitis A in vaccinated populations to the transformation of hepatitis C from a chronic, often fatal disease to a curable one. These advances remind us how far we’ve come in understanding and combating these liver viruses.

Sources

Centers for Disease Control and Prevention (https://www.cdc.gov)
World Health Organization (https://www.who.int)
Cleveland Clinic (https://my.clevelandclinic.org)
National Center for Biotechnology Information (https://www.ncbi.nlm.nih.gov)
American Academy of Pediatrics (https://www.aap.org)
PBS NewsHour (https://www.pbs.org)
FactCheck.org (https://www.factcheck.org)
Government of Quebec (https://www.quebec.ca/en/health/health-issues/stbbis/hepatitis-a-b-and-c)

Understanding Dementia: A Journey Through Memory Loss

By John Turley

On January 8, 2026

In Medicine

When someone tells you they’re having trouble remembering where they put their keys, that’s probably just normal aging. But when they forget what keys are for altogether, that’s when doctors start thinking about dementia. It’s a distinction that matters deeply to millions of families navigating one of medicine’s most challenging conditions.

While reviewing some of my previous articles, I realized that while I have discussed conditions that mimic dementia, I haven’t discussed dementia itself. This discussion has quite a bit of technical jargon, but it’s unavoidable.

Dementia isn’t a specific disease—it’s an umbrella term describing a decline in mental ability that interferes with daily life. Think of it like how “cancer” describes many different diseases. About 50 percent of people age 85 and older have some form of dementia, making it one of the most pressing health challenges of our aging population.

The Major Players: Types of Dementia

Alzheimer’s Disease stands as the heavyweight champion of dementia causes, accounting for an estimated 50 to 70 percent of all cases. What’s happening in the brain is both complicated and tragic. Beta-amyloid and phosphorylated tau proteins accumulate and spread through distributed neural networks in the brain, causing progressive metabolic abnormalities, neuronal injury, and cellular death all of which disrupt functional connectivity. The hallmark symptoms include problems with short-term memory: paying bills, preparing meals, remembering appointments, or getting lost in familiar areas. Your grandmother might remember vivid details from her childhood but can’t recall what she ate for breakfast or even recognize you.

Vascular Dementia comes in second place, accounting for about 5 to 15 percent of cases. Typical symptoms include slowed thinking, trouble with organization, difficulty planning or following instructions, and in the later phases, gait problems and urinary difficulties. It results from strokes or other problems with blood flow to the brain. On occasion it may be the result of a series of subclinical strokes with the victim being unaware of the individual events. Symptoms gradually become worse as blood vessels get damaged. Imagine the brain like a city—when the roads get blocked, supplies can’t get through, and neighborhoods start to fail.

Lewy Body Dementia Involves the deposit of abnormal alpha-synuclein proteins called Lewy bodies. It presents a particularly unsettling picture. Many people with this type of dementia experience daytime sleepiness, confusion, fluctuating cognition, staring spells, sleep disturbances, visual hallucinations, or movement problems. The visual hallucinations are generally vivid images of people or animals and often occur when someone is about to fall asleep or wake up.

Frontotemporal Dementia often hits younger people. It is caused by abnormalities in the proteins FUS and TDP-43. Most cases are diagnosed in people aged 45 to 65. Rather than starting with memory loss, early symptoms may include personality changes like reduced sensitivity to others’ feelings, lack of social awareness, making inappropriate jokes, language problems, obsessive behavior, or sudden outbursts of anger. It’s heartbreaking when someone’s personality fundamentally changes before your eyes.

LATE is a newly recognized form of dementia (Limbic-predominant Age-related TDP-43 Encephalopathy), which causes symptoms similar to Alzheimer’s but has different underlying causes involving abnormal clusters of TDP-43 protein. Research suggests that almost 40 percent of people whose age at death was 88 years or greater may have had LATE of varying degrees.

Less Common Forms: Parkinson’s disease dementia (movement disorder first, dementia later).Normal Pressure Hydrocephalus (NPH)—one of the few reversible types. Chronic traumatic encephalopathy (CTE)—linked to repeated head injuries.HIV-associated dementia—less common with modern treatment. Severe vitamin deficiencies (e.g., B1 or B12)—reversible if caught early.

Figuring Out What’s Wrong: The Diagnostic Process

Making a dementia diagnosis isn’t like getting a strep test or an Xray—there’s no single definitive test. Physicians use diagnostic tools combined with medical history and other information, including neurological exams, cognitive and functional assessments, brain imaging like MRI or CT, and cerebrospinal fluid or blood tests.

The process starts with your doctor asking detailed questions about your symptoms and medical history. Typical questions include asking about whether dementia runs in the family, how and when symptoms began, changes in behavior and personality, and if the person is taking certain medications that might cause or worsen symptoms. There are various cognitive tests—like the infamous clock face drawing—that physicians can use to assess the likelihood of dementia.

Brain imaging can play a crucial role for some patients. Structural imaging with MRI or CT is primarily used to rule out other conditions that may cause symptoms similar to dementia but that require different treatment. They can reveal tumors, evidence of strokes, damage from head trauma, or fluid buildup in the brain. Common MRI findings include brain atrophy, particularly shrinkage of the hippocampus which supports learning and memory and the cortex which supports perception, thought and voluntary action. Other findings may include white matter changes that affect communication between brain regions. Lesions from small strokes may be identified.

More sophisticated imaging like PET scans can detect specific proteins associated with Alzheimer’s. Recent advances in molecular imaging allow for visualization of amyloid and tau deposits in a living human brain, bringing us closer to an in vivo (while alive) definitive diagnosis. This is significant because historically Alzheimer’s could only be definitively diagnosed at autopsy.

Treatment Options: Managing the Unmanageable

Here’s where I need to be honest: there’s no cure for dementia. But that doesn’t mean we’re helpless. Several medications can help manage symptoms and potentially slow progression.

For Alzheimer’s specifically, the FDA has approved two categories of drugs. These include drugs that change disease progression in people living with early Alzheimer’s disease, and drugs that may temporarily mitigate some symptoms. The newer disease-modifying drugs include donanemab and lecanemab. They are anti-amyloid antibody intravenous infusion therapies that have demonstrated that removing beta-amyloid from the brain reduces cognitive and functional decline in people living with early Alzheimer’s.

More traditional treatments focus on symptom management. Medications such as galantamine, rivastigmine, and donepezil improve communication between nerve cells. Cholinesterase inhibitors work by preventing the breakdown of acetylcholine, a neurotransmitter, which may stabilize dementia symptoms.

Beyond medications, lifestyle modifications matter. Lifestyle changes including eating a balanced diet full of fruits and vegetables may help slow progression. Maintaining a routine to avoid confusion, including regular exercise and sleep, all help keep people with dementia as functional as possible for as long as possible. Staying mentally active and socially connected can help slow the onset and progression of dementia.

What to Expect: The Prognosis

This is the hardest part to talk about. The life expectancy of dementia patients varies enormously. Most people older than 65 with Alzheimer’s die within four to eight years of being diagnosed, but some people live for decades, especially if they were diagnosed before turning 65.

Life expectancy depends on a huge range of factors including the type of dementia diagnosed, overall health, and the age of diagnosis. Vascular dementia typically has a shorter life expectancy than Alzheimer’s disease due to underlying cardiovascular problems.

Progression happens in stages. Early symptoms include finding it hard to carry out familiar daily tasks, struggling to follow conversations or find the right word, and getting confused with familiar places. Signs of late-stage dementia include speaking in single words or repeated phrases that don’t make sense, not being able to understand what people are saying, or following things that are happening around them.

Those living with advanced dementia are especially prone to infection, constipation, skin ulcers and blood clots, which can put their life in danger if treatment is delayed. Dehydration and malnutrition are serious risks for those without a strong support network as they often forget to eat or drink. They are also more likely to be injured in falls and other accidents.

Ultimately, as you lose more brain function, activities vital to life begin to be affected, including breathing, swallowing, digestion, heart rate and sleep. Most people don’t die directly from dementia but from complications like pneumonia or falls.

A Note on Hope

Reading about dementia can feel depressing, but there’s reason for cautious optimism. While individual prognosis varies significantly and can’t be predicted with precision, early detection of symptoms and an early diagnosis can help with planning ahead to manage the disease. Scientists continue researching new treatments, particularly regarding new biomarkers and disease modifying drugs. Life expectancy estimates are improving all the time as many people are diagnosed earlier and receive better treatment and care.

________________________________________________________________________

Sources

National Institute on Aging – What Is Dementia? Symptoms, Types, and Diagnosis https://www.nia.nih.gov/health/alzheimers-and-dementia/what-dementia-symptoms-types-and-diagnosis
NHS – Symptoms of Dementia https://www.nhs.uk/conditions/dementia/symptoms-and-diagnosis/symptoms/
Cleveland Clinic – Dementia: What It Is, Causes, Symptoms, Treatment & Types https://my.clevelandclinic.org/health/diseases/9170-dementia
CDC – About Dementia https://www.cdc.gov/alzheimers-dementia/about/index.html
Cleveland Clinic – Alzheimer’s Disease: Symptoms & Treatment https://my.clevelandclinic.org/health/diseases/9164-alzheimers-disease
Wikipedia – Dementia https://en.wikipedia.org/wiki/Dementia
Practical Neurology – Brain Imaging in Differential Diagnosis of Dementia https://practicalneurology.com/diseases-diagnoses/imaging-testing/brain-imaging-in-differential-diagnosis-of-dementia/31533/
Healthgrades – Vascular Dementia Life Expectancy: Statistics and Disease Progression https://resources.healthgrades.com/right-care/dementia/vascular-dementia-prognosis-and-life-expectancy
Healthgrades – Dementia Life Expectancy: Stages and Progression https://resources.healthgrades.com/right-care/dementia/dementia-prognosis-and-life-expectancy
Elder – Dementia and Life Expectancy: Planning for the Future https://www.elder.org/dementia-care/dementia-life-expectancy/
Medical News Today – Dementia Life Expectancy: Duration and Stages https://www.medicalnewstoday.com/articles/how-long-does-dementia-last
Alzheimer’s Association – Medications for Memory, Cognition & Dementia-Related Behaviors https://www.alz.org/alzheimers-dementia/treatments/medications-for-memory
Alzheimer’s Association – Medical Tests for Diagnosing Alzheimer’s & Dementia https://www.alz.org/alzheimers-dementia/diagnosis/medical_tests
DRI Health Group – Can MRI Diagnose Dementia? https://drihealthgroup.com/health-tips/can-mri-diagnose-dementia

America’s Healthcare Paradox: Why We Pay Double and Get Less

By John Turley

On January 5, 2026

In Commentary, Medicine

The healthcare debate in America often circles back to a fundamental question: should we move toward a single-payer system, or is our current mixed public-private model the better path forward? It’s a conversation that gets heated quickly, but when you strip away the politics and look at how different systems actually function around the world, some interesting patterns emerge.

What We Mean by Single-Payer

A single-payer healthcare system means that one entity—usually the government or a government-related organization—pays for all covered healthcare services. Doctors and hospitals can still be private (and usually are), but instead of dealing with dozens of different insurance companies, they bill one source. It’s a lot like Medicare, which is why proponents often call it “Medicare-for-all”.

The key thing to understand is that single-payer isn’t necessarily the same as socialized medicine. In Canada’s system, for instance, the government pays the bills, but doctors are largely in the private sector and hospitals are controlled by private boards or regional health authorities rather than being part of the national government. Compare that to the UK’s National Health Service, where many hospitals and clinics are government-owned and many doctors are government employees.

America’s Current Patchwork

The United States operates what might charitably be called a “creative” approach to healthcare—a complex mix of employer-sponsored private insurance, government programs like Medicare, Medicaid and the VA system, individual marketplace plans, and direct out-of-pocket payments. Government already pays roughly half of total US health spending, but benefits, cost-sharing, and networks vary widely between plans, with little overall coordination. In 2023, private health insurance spending accounted for 30 percent of total national health expenditures, Medicare covered 21 percent, and Medicaid covered 18 percent. Most of the remainder was either paid out of pocket by private citizens or was written off by providers as uncollectible.

Here’s where it gets expensive. U.S. health care spending grew 7.5 percent in 2023, reaching $4.9 trillion or $14,570 per person, accounting for 17.6 percent of the nation’s GDP, and national health spending for 2024 is expected to have exceeded $5.3 trillion or 18% of GDP, and health spending is expected to grow to 20.3 percent of GDP by 2033.

For a typical American family, the costs are real and rising. In 2024, the estimated cost of healthcare for a family of four in an employer-sponsored health plan was $32,066.

The European Landscape

Europe doesn’t have one healthcare model—it has several, and they’re all quite different from what we have in the States. Most of the 35 countries in the European Union have single-payer healthcare systems, but the details vary considerably.

Countries like the UK, Sweden, and Norway operate what are essentially single-payer systems where it is solely the government who pays for and provides healthcare services and directly owns most facilities and employs most clinical and related staff with funds from tax contributions. Then you have countries like Germany, and Belgium that use “sickness funds”—these are non-profit funds that don’t market, cherry pick patients, set premiums or rates paid to providers, determine benefits, earn profits or have investors. They’re quasi-public institutions, not private insurance companies like we know them in America. Some systems, such as the Netherlands or Switzerland, rely on mandatory individually purchased private insurance with tight regulation and subsidies, achieving universal coverage with a structured, competitive market.

The French System

France is particularly noted for a successful universal, government-run health insurance system usually described as a single-payer with supplements. All legal residents are automatically covered through the national health insurance program, which is funded by payroll taxes and general taxation.

Most physicians and hospitals are private or nonprofit, not government employees or facilities. Patients generally have free choice of doctors and specialists, though coordinating through a primary care physician improves access and reimbursement. The national insurer pays a large portion of medical costs (often 70–80%), while voluntary private supplemental insurance covers most remaining out-of-pocket expenses such as copays and deductibles.

France is known for spending significantly less per capita than the United States. Cost controls come from nationally negotiated fee schedules and drug pricing rather than limits on access.

What’s striking is that in 2019, US healthcare spending reached $11,072 per person—over double the average of $5,505 across wealthy European nations. Yet despite spending roughly twice as much per person, American health outcomes often lag behind.

The Outcomes Question

This is where the comparison gets uncomfortable for American exceptionalism. The U.S. has the lowest life expectancy at birth among comparable wealthy nations, the highest death rates for avoidable or treatable conditions, and the highest maternal and infant mortality.

In 2023, life expectancy in comparable countries was 82.5 years, which is 4.1 years longer than in the U.S. Japan manages this with healthcare spending at just $5,300 per capita, while Americans spend more than double that amount.

Now, it’s important to note that healthcare systems don’t operate in a vacuum. Life expectancy is influenced by many factors beyond medical care—diet, exercise, smoking, gun violence, drug overdoses, and social determinants of health all play roles. But when you’re spending twice as much and getting worse results, it suggests the system itself might be part of the problem.

Advantages of Single-Payer Systems

The case for single-payer rests on several compelling points. First, administrative simplicity translates to real cost savings. A study found that the administrative burden of health care in the United States was 27 percent of all national health expenditures, with the excess administrative cost of the private insurer system estimated at about $471 billion in 2012 compared to a single-payer system like Canada’s. That’s over $1 out of every $5 of total healthcare spending just going to paperwork, billing disputes, and insurance company profit and overhead before any patient receives care.

Universal coverage is another major advantage. In a properly functioning single-payer system, nobody goes bankrupt from medical bills, nobody delays care because they can’t afford it, and nobody loses coverage when they lose their job. The peace of mind that comes with knowing you’re covered regardless of employment status or pre-existing conditions is difficult to quantify but enormously valuable.

Single-payer systems also have significant negotiating power. When one entity is buying drugs and services for an entire nation, pharmaceutical companies and medical device manufacturers have much less leverage to charge whatever they want. This helps explain why prescription drug prices in other countries are often a fraction of prices in the U.S.

Disadvantages and Trade-offs

The critics of single-payer systems aren’t wrong about everything. Wait times are a genuine concern in some systems. When prices and overall budgets are tightly controlled, some countries experience longer waits for selected elective surgeries, imaging, or specialty visits, especially if investment lags demand.

In 2024, Canadian patients experienced a median wait time of 30 weeks between specialty referral and first treatment, up from 27.2 weeks in 2023, with rural areas facing even longer delays. For procedures like elective orthopedic surgery, patients wait an average of 39 weeks in Canada.

However, it’s crucial to understand that wait times are not a result of the single-payer system itself but of system management, as wait times vary significantly across different single-payer and social insurance systems. Many European countries with universal coverage don’t experience the same wait time issues that plague Canada.

The transition costs are also substantial. Moving from our current system to single-payer would disrupt a massive industry. Over fifteen percent of our economy is related to health care, with half spent by the private sector. Around 160 million Americans currently have insurance through their employers, and transitioning all of them to a government-run plan would be an enormous administrative and political challenge.

A large national payer can be slower to change benefit designs or adopt new payment models; shifting political majorities can affect funding levels and benefit generosity.

Taxes would need to increase significantly to fund such a system, though proponents argue this would be offset by the elimination of insurance premiums, deductibles, and co-pays. It’s essentially a question of whether you’d rather pay through taxes or through premiums—the money has to come from somewhere.

Advantages of America’s Mixed System

Our current system does have some genuine strengths. Innovation thrives in the American healthcare market. The profit motive, for all its flaws, does drive pharmaceutical research and medical device development. American medical schools and research institutions lead the world in many areas of medicine. Academic medical centers and specialty hospitals deliver advanced procedures and complex care that attract patients internationally.

The system also offers more choice for those who can afford it. If you have good insurance, you typically face shorter wait times for elective procedures and can often see specialists without lengthy delays. Americans with high-quality employer-sponsored coverage give their plans relatively high ratings.

Competition between providers can theoretically drive quality improvements, though this effect is often undermined by the complexity of the market and the difficulty consumers face in shopping for healthcare.

Disadvantages of the Current U.S. System

The most glaring problem is simple: The United States remains the only developed country without universal healthcare, and 30 million Americans remain uninsured despite gains under the Affordable Care Act, and many of these gains will soon be lost. Being uninsured in America isn’t just an inconvenience—it can be deadly. People delay care, skip medications, and avoid preventive screenings because of cost concerns.

The administrative complexity is staggering. Doctors spend enormous amounts of time dealing with insurance companies, prior authorizations, and billing disputes. Hospitals employ armies of billing specialists just to navigate the maze of different insurance plans, each with its own rules, formularies, and coverage determinations. U.S. administrative costs account for ~25% of all healthcare spending, among the highest in the world.

Medical bankruptcy is uniquely American. Even people with insurance can find themselves financially devastated by serious illness. High deductibles, surprise bills, and out-of-network charges create a minefield of potential financial catastrophe. Studies of U.S. bankruptcy filings over the past two decades have consistently found that medical bills and medical problems are a major factor in a large share of consumer bankruptcies. Recent summaries suggest that roughly two‑thirds of US personal bankruptcies involve medical expenses or illness-related income loss, and around 17% of adults with health care debt report declaring bankruptcy or losing a home because of that debt.

The system is also profoundly inequitable. Quality of care often depends more on your job, your income, and your zip code than on your medical needs. Out-of-pocket costs per capita have increased as compared to previous decades and the burden falls disproportionately on those least able to afford it.

What Europe Shows Us

The European experience demonstrates that there isn’t one “right” way to achieve universal coverage. The UK’s NHS, Germany’s sickness funds, and France’s hybrid system all manage to cover everyone at roughly half the per-capita cost of American healthcare. Universal Health Coverage exists in all European countries, with healthcare financing almost universally government managed, either directly through taxation or semi-directly through mandated and government-subsidized social health insurance.

They’ve accomplished this through various combinations of centralized negotiation of drug prices, global budgets for hospitals, strong primary care systems that serve as gatekeepers to more expensive specialist care, emphasis on preventive services, and regulation that prevents insurance companies from cherry-picking healthy patients.

Are these systems perfect? No. One of the major disadvantages of centralized healthcare systems is long wait lists to access non-urgent care, though Americans often wait as long or longer for routine primary care appointments as do patients in most universal-coverage countries. Many European countries are wrestling with funding challenges as populations age and expensive new treatments become available. But they’ve solved the fundamental problem that America hasn’t: they ensure everyone has access to healthcare without the risk of financial ruin.

The Path Forward?

The debate over healthcare in America often presents false choices. We don’t have to choose between Canadian-style single-payer and our current system—there are multiple models we could adapt. We could move toward a German-style system with heavily regulated non-profit insurers. We could create a robust public option that competes with private insurance. We could expand Medicare gradually by lowering the eligibility age over time.

What’s clear from international comparisons is that the status quo is unusually expensive and produces mediocre results. We’re paying premium prices for economy outcomes. Whether single-payer is the answer depends partly on your priorities. Do you value universal coverage and cost control more than unlimited choice? Are you willing to accept potentially longer wait times for non-urgent care in exchange for lower costs and universal access? How much do you trust government to manage a program this large?

These aren’t easy questions, and reasonable people disagree. But the evidence from Europe suggests that universal coverage at reasonable cost is achievable—it just requires us to make some choices about what we value most in a healthcare system.

Sources:

Centers for Medicare & Medicaid Services National Health Expenditure Data: https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/historical
Commonwealth Fund international comparisons: https://www.commonwealthfund.org/publications/issue-briefs/2023/jan/us-health-care-global-perspective-2022
Peterson-KFF Health System Tracker: https://www.healthsystemtracker.org/chart-collection/u-s-life-expectancy-compare-countries/
Wikipedia overview of single-payer systems: https://en.wikipedia.org/wiki/Single-payer_healthcare
Harvard Health discussion of single-payer: https://www.health.harvard.edu/blog/single-payer-healthcare-pluses-minuses-means-201606279835
BMC study on administrative costs: Referenced in Wikipedia article on single-payer healthcare
Fraser Institute wait times data: https://www.fraserinstitute.org/studies/waiting-your-turn-wait-times-for-health-care-in-canada-2024
Healthcare systems comparison (European models): https://www.healthcare-now.org/euhealthcare/

Grumpy opinions about everything.

Category: Medicine Page 1 of 7

Fitness for Seniors: A Practical Guide to Getting Started and Staying Active

The Frozen Frontier: Understanding Cryonics and the Quest to Cheat Death

Strengthening Your Defenses: Understanding and Improving Immune Health in Your Golden Years

VO₂ Max Explained: The Fitness Metric That Predicts Health and Longevity

Fecal Microbiota Transplantation: When Waste Becomes Therapy

The Price Tag Mystery: Why Nobody Really Knows What Healthcare Costs in America

Hepatitis B Vaccine: Three Shots and You’re Done for Life?

Understanding Hepatitis: A Guide to Types A, B, and C

Understanding Dementia: A Journey Through Memory Loss

America’s Healthcare Paradox: Why We Pay Double and Get Less